Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Total 13F shares
-
61,878,560
-
Share change
-
-108,309
-
Total reported value
-
$2,746,621,087
-
Put/Call ratio
-
263%
-
Price per share
-
$44.37
-
Number of holders
-
169
-
Value change
-
-$19,110,347
-
Number of buys
-
94
-
Number of sells
-
77
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q1 2021
As of 31 Mar 2021,
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,878,560 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, and LORD, ABBETT & CO. LLC.
This page lists
170
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.